Jointly Sponsored by: The Perelman School of Medicine at the University of Pennsylvania,
The Penn Cener for AIDS Research and ViralEd, Inc.
UPenn CME - 2019          UPenn CFAR           VE Logo 2019
Faculty: Pieter-Paul S. Robbertse PhD, MBChB
Date/Time: Thursday, April 20, 2023 at 12:00 PM EDT
Topic: Seeing the unseen: Subclinical cardiomyopathy in newly diagnosed persons with HIV
Scoll down to access the program LOG-IN window at the bottom of this page!


The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to announce the extension of this ground-breaking CME activity. Mirroring academic grand rounds programs, these CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The "HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania" is delivered live via the Internet every Thursday at 12:00pm Eastern Time and is available for on-demand viewing immediately following the live broadcast.

Presentations cover the most important and current topics in HIV/AIDS and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing HIV clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These weekly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their HIV-positive patients.

Each session may be broadcast via your Internet connection individually to your personal computer at your convenience. Simply register at for easy access.


This program has been designed for Family Medicine, Pediatrics, Neurology, Psychiatry, Internal Medicine, Internal Medicine - Infectious Disease.


Gilead Sciences Medical Affairs, Janssen Therapeutics, ViiV Healthcare, and Merck Sharp & Dohme Corp.


After participating in this regularly scheduled series, participants should be able to:

  • Describe how to apply in clinical practice approaches for preventing HIV infection and getting newly diagnosed patients rapidly into care
  • Discuss how to individualize ARV therapy for the treatment-naïve and treatment-experienced patients to support adherence and patient satisfaction
  • Describe how to manage various patient populations, such as the aging patient with HIV infection, including issues associated with cardiovascular and bone disease, PWIDs, and underserved populations
  • Discuss the basic science concepts involved with HIV and be able to apply those concepts to HIV therapeutics, epidemiology, and other issues involved in HIV patient care and HIV prevention


After participating in this regularly scheduled series, participants should be able to:

  • Review the contrasting HIV-related cardiovascular disease profiles observed in high income countries vs. low- to middle income countries.
  • Recognise the role of cardiovascular magnetic resonance imaging to detect morphological, functional and tissue characterisation abnormalities in people living with HIV.
  • Discuss the potential for subclinical cardiovascular abnormalities to progress to symptomatic heart disease, if underlying pathological processes are not adequately addressed. 

Robbertse, Pieter-Paul  Pieter-Paul S. Robbertse PhD, MBChB
Cardiovascular Magnetic Resonance Physician and Postdoctoral fellow
NIH/Fogarty D43 fellow: University of Pittsburgh HIV-Comorbidities Research Training Program in South Africa
Division of Cardiology
Department of Medicine
Faculty of Medicine and Health Sciences
Tygerberg Hospital and Stellenbosch University
Cape Town, South Africa


In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses/Pharmacists: This activity is not approved for nursing or pharmacy contact hours

PAs: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.00 Category 1 credits for completing this activity.


It is policy at Penn Medicine Office of Continuing Medical and Interprofessional Education for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or services that may be relevant to the content of this continuing education activity.  For this purpose, we consider relationships of the person involved to include financial relationships of a spouse or partner.

The intent of this policy is to ensure that Penn CME/CE certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.

The staff in the Office of Continuing Medical and Interprofessional Education (CME and IPCE)  have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity. Any peer reviewer with a potential conflict of interest will recuse themselves from the peer review process.

The following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:

  • Florence Momplaisir, MD (Program Co-Director)
  • ViralEd, Inc: Brian Boyle; Oliver Fultz; Rick Gordon
  • Pieter-Paul S. Robbertse PhD, MBChB (Presenter)

The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:

  •  Ian Frank, MD (Program Co-Director)
    • Advisor/Review Panel Member: Gilead; ViiV
    • Consulting Fee: Johnson & Johnson; Moderna; Gilead (Relationship Ended); Merck (Relationship Ended)
    • Grants/Research Support: Johnson & Johnson; Moderna; Pfizer; Sanofi Genzyme (Relationship Ended)
    Katherine Bar, MD (Program Co-Director)
    • Consulting Fee: Abbvie (Relationship Ended)

Relevant financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected.


  • Pieter-Paul S. Robbertse PhD, MBChB: None.
HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania: Thursday, April 20, 2023
Your name *
Email address *
Degree/Profession *
Country *
How many participants are watching using your internet connection? *
* Required